Sato AK - Search Results

1

Phage display-derived peptides as therapeutic alternatives to antibodies.

Ladner RC, Sato AK, Gorzelany J, de Souza M. Ladner RC, et al. Among authors: sato ak. Drug Discov Today. 2004 Jun 15;9(12):525-9. doi: 10.1016/S1359-6446(04)03104-6. Drug Discov Today. 2004. PMID: 15183160 Review.

2

Development of mammalian serum albumin affinity purification media by peptide phage display.

Sato AK, Sexton DJ, Morganelli LA, Cohen EH, Wu QL, Conley GP, Streltsova Z, Lee SW, Devlin M, DeOliveira DB, Enright J, Kent RB, Wescott CR, Ransohoff TC, Ley AC, Ladner RC. Sato AK, et al. Biotechnol Prog. 2002 Mar-Apr;18(2):182-92. doi: 10.1021/bp010181o. Biotechnol Prog. 2002. PMID: 11934284

3

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases.

Shrivastava A, von Wronski MA, Sato AK, Dransfield DT, Sexton D, Bogdan N, Pillai R, Nanjappan P, Song B, Marinelli E, DeOliveira D, Luneau C, Devlin M, Muruganandam A, Abujoub A, Connelly G, Wu QL, Conley G, Chang Q, Tweedle MF, Ladner RC, Swenson RE, Nunn AD. Shrivastava A, et al. Among authors: sato ak. Protein Eng Des Sel. 2005 Sep;18(9):417-24. doi: 10.1093/protein/gzi049. Epub 2005 Aug 8. Protein Eng Des Sel. 2005. PMID: 16087652

4

Therapeutic peptides: technological advances driving peptides into development.

Sato AK, Viswanathan M, Kent RB, Wood CR. Sato AK, et al. Curr Opin Biotechnol. 2006 Dec;17(6):638-42. doi: 10.1016/j.copbio.2006.10.002. Epub 2006 Oct 17. Curr Opin Biotechnol. 2006. PMID: 17049837 Review.

5

Discovery of human antibodies against the C5aR target using phage display technology.

Huang L, Sato AK, Sachdeva M, Fleming T, Townsend S, Dransfield DT. Huang L, et al. Among authors: sato ak. J Mol Recognit. 2005 Jul-Aug;18(4):327-33. doi: 10.1002/jmr.735. J Mol Recognit. 2005. PMID: 15706605

6

Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro.

Frayser M, Sato AK, Xu L, Stern LJ. Frayser M, et al. Among authors: sato ak. Protein Expr Purif. 1999 Feb;15(1):105-14. doi: 10.1006/prep.1998.0987. Protein Expr Purif. 1999. PMID: 10024477

7

Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1.

Sato AK, Zarutskie JA, Rushe MM, Lomakin A, Natarajan SK, Sadegh-Nasseri S, Benedek GB, Stern LJ. Sato AK, et al. J Biol Chem. 2000 Jan 21;275(3):2165-73. doi: 10.1074/jbc.275.3.2165. J Biol Chem. 2000. PMID: 10636922 Free article.

8

Substitution of aspartic acid at beta57 with alanine alters MHC class II peptide binding activity but not protein stability: HLA-DQ (alpha1*0201, beta1*0302) and (alpha1*0201, beta1*0303).

Sato AK, Sturniolo T, Sinigaglia F, Stern LJ. Sato AK, et al. Hum Immunol. 1999 Dec;60(12):1227-36. doi: 10.1016/s0198-8859(99)00120-2. Hum Immunol. 1999. PMID: 10626736

9

A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.

Zarutskie JA, Sato AK, Rushe MM, Chan IC, Lomakin A, Benedek GB, Stern LJ. Zarutskie JA, et al. Among authors: sato ak. Biochemistry. 1999 May 4;38(18):5878-87. doi: 10.1021/bi983048m. Biochemistry. 1999. PMID: 10231540

10

Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate.

Hills R, Mazzarella R, Fok K, Liu M, Nemirovskiy O, Leone J, Zack MD, Arner EC, Viswanathan M, Abujoub A, Muruganandam A, Sexton DJ, Bassill GJ, Sato AK, Malfait AM, Tortorella MD. Hills R, et al. Among authors: sato ak. J Biol Chem. 2007 Apr 13;282(15):11101-9. doi: 10.1074/jbc.M611588200. Epub 2007 Feb 20. J Biol Chem. 2007. PMID: 17311924 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page